This paper is a marketing audit of Bristol Myers Squibb (BMSC).
3,250 words (approx. 13 pages) |
16 sources |
APA | 2008
Paper Summary:
This paper presents an overview of pharmaceutical company, Bristol Myers Squibb (BMSC) and then presents an environmental analysis of the pharmaceutical industry with regards to how BMSC can obtain a competitive edge. The paper presents a strengths, weaknesses, opportunities, and threats (SWOT) analysis of BMSC and discusses BMSC market segmentation. The paper concludes with recommendations for a marketing strategy.
Table of Contents:
BMSC Overview
The Competitive Environment
Pfizer Overview
Competitor Profile Matrix
Industry Rivalry
Environmental Analysis
BMSC SWOT
Strengths
Weaknesses
Opportunities
Threats
BMSC Segmentation
Conclusion and Recommendations
Conclusions
Recommendations
Appendix
Company Background
SWOT Table
From the Paper:
"Pfizer had revenues of more than $52,000 million during 2004 which represented an increase of over 17% from the previous year. Pfizer's profit for 2004 was over $11,000 million which represented a year on year increase of over 300%. Financially Pfizer is a very strong company which markets pharmaceutical and consumer products in both human and animal markets concentrated in 3 segments: pharmaceuticals, consumer healthcare and animal healthcare. While continually investing in research and development, Pfizer is currently benefiting from 3 strong products in the marketplace: Viagra, Zoloft and Lipitor."
Sample of Sources Used:
Arnold, M. 2004. Pravachol's study backfires but Crestor takes the hit. Medical Marketing & Media, 39(4), p.8.
You will be able to download, read and edit this file once you buy this document
Shopping Cart
Currency:
Published by:
Quality Writers
Publisher Since:
Oct 23, 2007
We are a writing company that's been in business for over 7 years. We write top quality papers and have excellent feedback from all of our customers.